Adagrasib(Krazati)

Adagrasib is a highly selective, orally administered KRAS G12C inhibitor used for the treatment of patients with advanced cancers harboring a KRAS G12C mutation.

200mg*90tablets

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Adagrasib Medication Guide

Important Considerations for the Use of Adagrasib

What Is AdagrasibAdagrasib is a targeted agent directed againstKRAS G12C mutation, mainly used for the treatment ofnonsmall cell lung cancer (NSCLC)a···【Read More】
Update: 10 Mar,2026Source: Haiou HealthViews: 72
What Targeted Therapy Is Adagrasib Used For

Mechanism of Action and TargetTarget: KRAS G12C MutationKRAS mutation is one of the most common driver mutations in cancer.KRAS G12C is a frequent sub···【Read More】
Update: 10 Mar,2026Source: Haiou HealthViews: 72